Terug

Watch Compare

FRACTYL HEALTH, INC.

Datakwaliteit: 83%

GUTS

Nasdaq Manufacturing Measuring & Analyzing Instruments

€ 0,46

▼ € 0,01 (-1,74%)

Marktkapitalisatie: 72,50 M

Prijs

€ 0,46

Marktkapitalisatie

72,50 M

Dagbereik

€ 0,45 — € 0,47

52-Weeksbereik

€ 0,38 — € 3,03

Volume

706.004

Openen € 0,46

50D / 200D Gem.

€ 0,59

22,24% below

50D / 200D Gem.

€ 1,29

64,54% below

Quick Summary

Belangrijkste Punten

Negative free cash flow of -90,89 M

Groei

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Kwaliteit

Return on Equity

N/A

ROIC-112,67%

Net MarginN/A

Op. MarginN/A

Veiligheid

Debt / Equity

N/A

Current Ratio4,27

Interest CoverageN/A

Waardering

PE (TTM)

-0,51

Boven sectorgemiddelde (-1,48)

P/B RatioN/A

EV/EBITDAN/A

Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)

Metriek	Aandeel	Sector Mediaan
P/E	-0,5	-1,5
P/B	—	1,6
ROE %	—	-53,4
Net Margin %	—	-41,5
Rev Growth 5Y %	—	1,8
D/E	—	0,3

ETFs Holding This Stock

BRSIX BRSIX

0,08% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	N/A	Net Income (TTM)	-140,95 M
ROE	N/A	ROA	-159,92%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-90,89 M
ROIC	-112,67%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	4,27
Interest Coverage	N/A	Asset Turnover	N/A
Working Capital	61,02 M	Tangible Book Value	-3,18 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-0,51	Forward P/E	N/A
P/B Ratio	N/A	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-125,35%
Market Cap	72,50 M	Enterprise Value	-5,15 M
Per Share
EPS (Diluted TTM)	-1,86	Revenue / Share	N/A
FCF / Share	-0,57	OCF / Share	-0,57
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	64,48%
SBC-Adj. FCF	-100,93 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025	FY2024
Revenue	—	—
Net Income	-140,95 M	-68,69 M
EPS (Diluted)	-1,86	-1,62
Gross Profit	43.000,0	43.000,0
Operating Income	-96,82 M	-93,53 M
EBITDA	—	—
R&D Expenses	74,54 M	70,47 M
SG&A Expenses	22,28 M	23,10 M
D&A	—	—
Interest Expense	—	—
Income Tax	0,0	0,0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024
Total Assets	121,40 M	108,08 M
Total Liabilities	111,94 M	79,65 M
Shareholders' Equity	9,46 M	28,42 M
Total Debt	—	—
Cash & Equivalents	81,54 M	67,46 M
Current Assets	87,58 M	71,76 M
Current Liabilities	18,33 M	19,78 M